Bidirectional coupling among EMT, AXL-RB1 signaling and lineage switch drives resistance to osimertinib and worse clinical outcomes in NSCLC. - Vashista S; Meena RK; Kulkarni P; Salgia R; Thomas A; Jolly MK (BioRxiv : the preprint server for biology, 2026)